Literature DB >> 21029348

US trends in glycemic control, treatment, and comorbidity burden in patients with diabetes.

Fadia T Shaya1, Xia Yan, Pei-Jung Lin, Linda Simoni-Wastila, Morgan Bron, Robert Baran, Thomas W Donner.   

Abstract

This study explored trends over time in diabetes prevalence, glycemic control, and antidiabetic therapy choices among adults (18-64 years) and older adults (≥ 65 years). Factors that predict diabetes outcomes were explored. The study was cross-sectional, with data from the 1999 to 2004 National Health and Nutrition Examination Survey. The study group consisted of 1211 persons with self-reported diabetes. Other information obtained from the study included self-reported medication for diabetes, hypertension, stroke, heart failure, and health status. The survey also provided examination or laboratory tests of obesity, nephropathy, and glycosylated hemoglobin level. Descriptive and logistic regression analyses were used in the study. The study showed that the proportion of diabetics with good glycemic control increased during the period from 1999 to 2004. However, nearly half of the adults and one third of older adults with diabetes did not reach glycemic control in 2003-2004. Overall, 59% of adults and 46% of older adults were obese. There was a high prevalence of hypertension, heart failure, stroke, and nephropathy among patients with diabetes, especially in older adults. The results indicate a high percentage of poor glycemic control among persons with diabetes. There were also a substantial number of comorbid conditions associated with diabetes.
© 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21029348      PMCID: PMC8673194          DOI: 10.1111/j.1751-7176.2010.00365.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  24 in total

1.  Diabetes mellitus in older adults: underdiagnosis and undertreatment.

Authors:  J B Halter
Journal:  J Am Geriatr Soc       Date:  2000-03       Impact factor: 5.562

2.  Aiming for, believing in, and achieving a target A1c of less than 7.

Authors:  Steven Edelman
Journal:  J Am Pharm Assoc (Wash)       Date:  2003 Jan-Feb

3.  Standards of medical care for patients with diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

4.  Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S.

Authors:  Edward W Gregg; Betsy L Cadwell; Yiling J Cheng; Catherine C Cowie; Desmond E Williams; Linda Geiss; Michael M Engelgau; Frank Vinicor
Journal:  Diabetes Care       Date:  2004-12       Impact factor: 19.112

5.  Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes.

Authors:  Sharon H Saydah; Judith Fradkin; Catherine C Cowie
Journal:  JAMA       Date:  2004-01-21       Impact factor: 56.272

6.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

7.  Lifetime risk for diabetes mellitus in the United States.

Authors:  K M Venkat Narayan; James P Boyle; Theodore J Thompson; Stephen W Sorensen; David F Williamson
Journal:  JAMA       Date:  2003-10-08       Impact factor: 56.272

8.  Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report.

Authors:  Carol E Koro; Steven J Bowlin; Nancy Bourgeois; Donald O Fedder
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

9.  Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.

Authors:  Richard J Stevens; Ruth L Coleman; Amanda I Adler; Irene M Stratton; David R Matthews; Rury R Holman
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

10.  Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus.

Authors:  J Partanen; L Niskanen; J Lehtinen; E Mervaala; O Siitonen; M Uusitupa
Journal:  N Engl J Med       Date:  1995-07-13       Impact factor: 91.245

View more
  8 in total

1.  Comparison of demographic factors and cardiovascular risk factor control among U.S. adults with type 2 diabetes by insulin treatment classification.

Authors:  Kalina Wong; Diana Glovaci; Shaista Malik; Stanley S Franklin; Gail Wygant; Uchenna Iloeje; Hongjun Kan; Nathan D Wong
Journal:  J Diabetes Complications       Date:  2012-04-12       Impact factor: 2.852

2.  Determinants of successful glycemic control among participants in the BARI 2D trial: a post-hoc analysis.

Authors:  Faramarz Ismail-Beigi; Manuel S Lombardero; Jorge Escobedo; Saul Genuth; Jennifer Green; Elaine Massaro; Arshag D Mooradian; Fernando Ovalle; Fred Whitehouse; Joel Zonszein
Journal:  J Diabetes Complications       Date:  2013-03-07       Impact factor: 2.852

3.  Bariatric surgery as a treatment option in patients with type 2 diabetes mellitus.

Authors:  Marianna Spanou; Konstantinos Tziomalos
Journal:  World J Diabetes       Date:  2013-04-15

4.  Comparison of diabetes management status between cancer survivors and the general population: results from a Korean population-based survey.

Authors:  Ji-Yeon Shin; Hye Young Shim; Jae Kwan Jun
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

5.  The power of the group: comparison of interviews and group concept mapping for identifying patient-important outcomes of care.

Authors:  Kristin L Rising; Marianna LaNoue; Alexzandra T Gentsch; Amanda M B Doty; Amy Cunningham; Brendan G Carr; Judd E Hollander; Lori Latimer; Larry Loebell; Gail Weingarten; Neva White; Geoffrey Mills
Journal:  BMC Med Res Methodol       Date:  2019-01-08       Impact factor: 4.615

6.  Glycaemic control in patients with type 2 diabetes initiating second-line therapy: Results from the global DISCOVER study programme.

Authors:  Kamlesh Khunti; Hungta Chen; Javier Cid-Ruzafa; Peter Fenici; Marilia B Gomes; Niklas Hammar; Linong Ji; Mikhail Kosiborod; Stuart Pocock; Marina V Shestakova; Iichiro Shimomura; Fengming Tang; Hirotaka Watada; Antonio Nicolucci
Journal:  Diabetes Obes Metab       Date:  2019-10-01       Impact factor: 6.577

7.  Assessing the impact of medically tailored meals and medical nutrition therapy on type 2 diabetes: Protocol for Project MiNT.

Authors:  Kristin L Rising; Mackenzie Kemp; Patricia Davidson; Judd E Hollander; Serge Jabbour; Eric Jutkowitz; Benjamin E Leiby; Cheryl Marco; Ian McElwee; Geoffrey Mills; Laura Pizzi; Rhea E Powell; Anna Marie Chang
Journal:  Contemp Clin Trials       Date:  2021-07-24       Impact factor: 2.261

8.  Diabetes control is associated with environmental quality in the USA.

Authors:  Jyotsna S Jagai; Alison K Krajewski; Kyla N Price; Danelle T Lobdell; Robert M Sargis
Journal:  Endocr Connect       Date:  2021-08-25       Impact factor: 3.221

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.